Ozempic (semaglutide) summary of product characteristics
Recently, in these terms (activation of the collateral pathways, relayed on the given injury) [11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28], we reviewed the greater pleiotropic cytoprotection potential of the stable gastric pentadecapeptide BPC 157 as a novel cytoprotection mediator largely involved in healing (for review, see i.e., [1,2,3,4,5,6]), inside and outside the gastrointestinal tract (i.e., BPC 157 counteracted leaky gut (for review, see i.e., [4])
The acute toxicology in animal models appears relatively benign, but animal toxicology does not establish human safety across chronic exposure
This multi-targeted approach may explain why users report benefits across diverse injury types and body regions
FDA-approved products come in fixed doses